Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

161
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Sales27 38726 43126 50523 14224 60325 361
Operating income (EBITDA)10 2319 4158 8837 7977 9648 378
Operating profit (EBIT)8 5548 3308 0156 4766 6726 968
Pre-Tax Profit (EBT)7 6986 6926 6474 7085 1035 674
Net income5 2614 5655 6283 1643 4203 818
EPS (PNC)10391,511167,878,275,1
Dividend per Share (PNC)70,074,078,080,281,082,7
Yield5,08%5,37%5,66%5,81%5,87%6,00%
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Debt9 00314 03712 64512 86311 27211 277
Finance------
Operating income (EBITDA)10 2319 4158 8837 7977 9648 378
Leverage
(Debt/EBITDA)
0,88x1,49x1,42x1,65x1,42x1,35x
Capital Expenditure9231 0511 1881 3661 6111 409
Book Value Per Share (BVPS)162 PNC120 PNC146 PNC134 PNC147 PNC152 PNC
Cash Flow per Share124 PNC87,7 PNC149 PNC102 PNC113 PNC132 PNC
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 66 638 M GBP -
Entreprise Value (EV) 79 501 M GBP 77 910 M GBP
Valuation 2014e 2015e
PER (Price / EPS) 20,3x 17,6x
Capitalization / Revenue 2,88x 2,71x
EV / Revenue 3,44x 3,17x
EV / EBITDA 10,2x 9,78x
Yield (DPS / Price) 5,81% 5,87%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 28,0% 27,1%
operating Leverage (Delta EBIT / Delta Sales) -1,51x 0,48x
Net Margin (Net Profit / Revenue) 13,7% 13,9%
ROA (Net Profit / Asset) 8,80% 9,00%
ROE (Net Profit / Equities) 62,1% 69,2%
Rate of Dividend 118% 104%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,90% 6,55%
Cash Flow / Sales (Taux d'autofinancement) 21,4% 22,4%
Capital Intensity (Assets / Sales) 1,55x 1,54x
Financial Leverage (Net Debt / EBITDA) 1,65x 1,42x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF